PF-08046052

PF-08046052 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046052, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors [Phase 1]